On January 21, 2015, Hillhouse and Mayo Clinic announced a JV to advance the quality of healthcare in China. By combining Mayo Clinic’s patient care, medical research and education with Hillhouse’s China expertise and healthcare industry partnerships, the collaboration establishes a new company to improve healthcare delivery and efficiency in China.
The new venture named “Huimei Healthcare” will leverage Mayo’s medical resources and management experience with Hillhouse’s strong in-country knowledge to deliver high-quality healthcare services to Chinese healthcare providers and patients.
“Mayo is coming to China just at the right time.” As a key figure in making Mayo’s entering China a reality, Lei Zhang, Chairman and CEO of Hillhouse Capital Group, is very optimistic about the prospects of Huimei Healthcare, “The ultimate thinking brings both challenges and opportunities to the healthcare industry, but will eventually push our healthcare service system to focus on patients, where Mayo’s ‘patient first’ philosophy would enjoy great potential.
As part of the joint venture agreement, Mayo Clinic contributes to the JV with its industry know-how, continuing education and training systems for specialists, doctors, and nurses.